This company has been marked as potentially delisted and may not be actively trading. Cellular Biomedicine Group (CBMG) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Cellular Biomedicine Group Short Interest DataCellular Biomedicine Group (CBMG) has a short interest of 290,000 shares, representing 2.53% of the float (the number of shares available for trading by the public). This marks a 2.08% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.9, indicating that it would take 3.9 days of the average trading volume of 129,776 shares to cover all short positions.Current Short Interest290,000 sharesPrevious Short Interest284,100 sharesChange Vs. Previous Month+2.08%Dollar Volume Sold Short$5.12 millionShort Interest Ratio3.9 Days to CoverLast Record DateJanuary 29, 2021Outstanding Shares19,478,000 sharesFloat Size11,440,000 sharesShort Percent of Float2.53%Today's Trading Volume8,375 sharesAverage Trading Volume129,776 sharesToday's Volume Vs. Average6% Short Selling Cellular Biomedicine Group? Sign up to receive the latest short interest report for Cellular Biomedicine Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCBMG Short Interest Over TimeCBMG Days to Cover Over TimeCBMG Percentage of Float Shorted Over Time Cellular Biomedicine Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/29/2021290,000 shares $5.12 million +2.1%2.5%3.9 $17.67 1/15/2021284,100 shares $5.08 million -5.8%2.5%6.8 $17.88 12/31/2020301,600 shares $5.56 million +13.1%2.6%7.3 $18.45 12/15/2020266,600 shares $4.92 million -23.1%2.3%6 $18.46 11/30/2020346,600 shares $6.48 million -8.9%3.0%6.7 $18.70 11/15/2020380,400 shares $6.61 million +0.3%3.3%5.8 $17.37 10/30/2020379,100 shares $6.93 million -0.9%3.3%3 $18.28 10/15/2020382,500 shares $7.04 million +1.1%3.3%3.1 $18.40 9/30/2020378,300 shares $6.94 million -14.3%3.3%2.8 $18.34 9/15/2020441,400 shares $8.13 million +2.5%3.9%3.1 $18.41 8/31/2020430,800 shares $8.00 million +10.7%3.8%3 $18.58 8/14/2020389,200 shares $7.20 million -31.1%3.4%2.9 $18.51 7/31/2020564,700 shares $7.44 million +8.6%5.0%6.9 $13.17 7/15/2020520,100 shares $7.92 million -2.4%4.6%6 $15.23 CBMG Short Interest - Frequently Asked Questions What is Cellular Biomedicine Group's current short interest? Short interest is the volume of Cellular Biomedicine Group shares that have been sold short but have not yet been closed out or covered. As of January 29th, traders have sold 290,000 shares of CBMG short. 2.53% of Cellular Biomedicine Group's shares are currently sold short. Learn More on Cellular Biomedicine Group's current short interest. What is a good short interest ratio for Cellular Biomedicine Group? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CBMG shares currently have a short interest ratio of 4.0. Learn More on Cellular Biomedicine Group's short interest ratio. What is a good short interest percentage for Cellular Biomedicine Group? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.53% of Cellular Biomedicine Group's floating shares are currently sold short. Is Cellular Biomedicine Group's short interest increasing or decreasing? Cellular Biomedicine Group saw a increase in short interest in January. As of January 29th, there was short interest totaling 290,000 shares, an increase of 2.1% from the previous total of 284,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cellular Biomedicine Group's float size? Cellular Biomedicine Group currently has issued a total of 19,478,000 shares. Some of Cellular Biomedicine Group's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cellular Biomedicine Group currently has a public float of 11,440,000 shares. How does Cellular Biomedicine Group's short interest compare to its competitors? 2.53% of Cellular Biomedicine Group's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Cellular Biomedicine Group: Prime Medicine, Inc. (39.00%), Inhibikase Therapeutics, Inc. (4.93%), Protalix BioTherapeutics, Inc. (4.74%), Achilles Therapeutics plc (1.26%), ZIVO Bioscience, Inc. (1.77%), bluebird bio, Inc. (2.91%), Cyclo Therapeutics, Inc. (3.55%), Finch Therapeutics Group, Inc. (0.01%), NKGen Biotech, Inc. (1.16%), AlloVir, Inc. (2.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: GameStop Corp. ($6.96 billion), DuPont de Nemours, Inc. ($5.44 billion), Charter Communications, Inc. ($5.39 billion), Aon plc ($4.87 billion), Analog Devices, Inc. ($4.45 billion), Snap Inc. ($3.29 billion), Moderna, Inc. ($3.19 billion), The Clorox Company ($2.24 billion), Palantir Technologies Inc. ($2.18 billion), and Snowflake Inc. ($2.17 billion). View all of the most shorted stocks. What does it mean to sell short Cellular Biomedicine Group stock? Short selling CBMG is an investing strategy that aims to generate trading profit from Cellular Biomedicine Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cellular Biomedicine Group? A short squeeze for Cellular Biomedicine Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CBMG, which in turn drives the price of the stock up even further. How often is Cellular Biomedicine Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CBMG, twice per month. The most recent reporting period available is January, 29 2021. More Short Interest Resources from MarketBeat Related Companies PRME Short Interest Data IKT Short Interest Data PLX Short Interest Data ACHL Short Interest Data ZIVO Short Interest Data BLUE Short Interest Data CYTH Short Interest Data FNCH Short Interest Data NKGN Short Interest Data ALVR Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CBMG) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellular Biomedicine Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellular Biomedicine Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.